Delivery Order SPE2DB20D2014-SPE2DB25FA20L

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,507.78 firm fixed-price delivery order is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of October 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with a ceiling value of $1,367.04. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,644.96, is for the delivery of 1,200,000 units of Bicillin L-A, a medication, and is designated as a Firm Fixed Price Delivery Order. The contract has a performance period running through January 8, 2025. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.91 firm fixed-price delivery order contract is for the supply of 1,200,000 units of Bicillin L-A, a medication, to support military healthcare programs. The contract has an ultimate completion date of May 30, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 1,200,000 units of Bicillin L-A, a penicillin-based injectable medication, with a ceiling value of $2,001.35. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a comprehensive vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,835.32, is a Firm Fixed Price Delivery Order for the supply of 1,200,000 units of Bicillin L-A, a prescription medication. The contract has an ultimate completion date of November 15, 2023 and was awarded on November 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, with a ceiling value of $112,824.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a medication, with an ultimate completion date of April 1, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,175.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of April 24, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,443.54, is for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, with a period of performance through February 6, 2025. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. AmerisourceBergen holds a substantial...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,585.35, is for the supply of 2,400,000 units of Bicillin L-A, a medication used for the treatment of various bacterial infections. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA20L
    Delivery Order

The federal contract awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, at a ceiling value of $1,175.24. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned in the provided information.

Generated 1/24/25, 9:16 AM